Ledger.Open graph →
SEC Form D · Amendment · filed June 17, 2021

OncoNano Medicine, Inc

Offering
$60.0M
Sold
$49.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Southlake, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Yumin Qiu · Southlake, TXDirectorAlvaro Guillem · Southlake, TXDirectorJoydeep Goswami · Southlake, TXDirectorMatthew Head · Southlake, TXExecJohn Dyett · Southlake, TXDirectorMartin Driscoll · Southlake, TXExec · DirectorNoel Ford · Dublin 2, IrelandDirectorBronwyn Wright · Dublin 2, IrelandExecAaron I. Payas · Queensway, J1Exec · DirectorWalter J. Novicki · Fort Myers, FLDirectorTara Iii LLC · Santa Monica, CADirectorCristobal Perdomo Riveros · Ciudad de Mexico, O5DirectorAshish P. Sanghrajka · New York, NYDirectorEric W. Chan · San Francisco, CADirectorPaul J. Hopper · New York, NYExecJeffrey R. Bartfeld · San Francisco, CADirectorScott Conway · Incline Village, NVExec · DirectorSheldon Inwentash · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗